Cargando…
DNMT1 is a negative regulator of osteogenesis
The role and underlying mechanisms of DNA methylation in osteogenesis/chondrogenesis remain poorly understood. We here reveal DNA methyltransferase 1 (DNMT1), which is responsible for copying DNA methylation onto the newly synthesized DNA strand after DNA replication, is overexpressed in sponge bone...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905718/ https://www.ncbi.nlm.nih.gov/pubmed/35238333 http://dx.doi.org/10.1242/bio.058534 |
_version_ | 1784665251119104000 |
---|---|
author | Tao, Chen Liu, Jia Li, Ziqi Lai, Pinglin Zhang, Sheng Qu, Jiankun Tang, Yujin Liu, Anling Zou, Zhipeng Bai, Xiaochun Li, Jianwei |
author_facet | Tao, Chen Liu, Jia Li, Ziqi Lai, Pinglin Zhang, Sheng Qu, Jiankun Tang, Yujin Liu, Anling Zou, Zhipeng Bai, Xiaochun Li, Jianwei |
author_sort | Tao, Chen |
collection | PubMed |
description | The role and underlying mechanisms of DNA methylation in osteogenesis/chondrogenesis remain poorly understood. We here reveal DNA methyltransferase 1 (DNMT1), which is responsible for copying DNA methylation onto the newly synthesized DNA strand after DNA replication, is overexpressed in sponge bone of people and mice with senile osteoporosis and required for suppression of osteoblast (OB) differentiation of mesenchymal stem cells (MSCs) and osteoprogenitors. Depletion of DNMT1 results in demethylation at the promoters of key osteogenic genes such as RORA and Fgfr2, and consequent upregulation of their transcription in vitro. Mechanistically, DNMT1 binds exactly to the promoters of these genes and are responsible for their 5-mc methylation. Conversely, simultaneous depletion of RORA or Fgfr2 blunts the effects of DNMT1 silencing on OB differentiation, suggesting RORA or Fgfr2 may be crucial for modulating osteogenic differentiation downstream of DNMT1. Collectively, these results reveal DNMT1 as a key repressor of OB differentiation and bone formation while providing us a new rationale for specific inhibition of DNMT1 as a potential therapeutic strategy to treat age-related bone loss. |
format | Online Article Text |
id | pubmed-8905718 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Company of Biologists Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-89057182022-03-09 DNMT1 is a negative regulator of osteogenesis Tao, Chen Liu, Jia Li, Ziqi Lai, Pinglin Zhang, Sheng Qu, Jiankun Tang, Yujin Liu, Anling Zou, Zhipeng Bai, Xiaochun Li, Jianwei Biol Open Research Article The role and underlying mechanisms of DNA methylation in osteogenesis/chondrogenesis remain poorly understood. We here reveal DNA methyltransferase 1 (DNMT1), which is responsible for copying DNA methylation onto the newly synthesized DNA strand after DNA replication, is overexpressed in sponge bone of people and mice with senile osteoporosis and required for suppression of osteoblast (OB) differentiation of mesenchymal stem cells (MSCs) and osteoprogenitors. Depletion of DNMT1 results in demethylation at the promoters of key osteogenic genes such as RORA and Fgfr2, and consequent upregulation of their transcription in vitro. Mechanistically, DNMT1 binds exactly to the promoters of these genes and are responsible for their 5-mc methylation. Conversely, simultaneous depletion of RORA or Fgfr2 blunts the effects of DNMT1 silencing on OB differentiation, suggesting RORA or Fgfr2 may be crucial for modulating osteogenic differentiation downstream of DNMT1. Collectively, these results reveal DNMT1 as a key repressor of OB differentiation and bone formation while providing us a new rationale for specific inhibition of DNMT1 as a potential therapeutic strategy to treat age-related bone loss. The Company of Biologists Ltd 2022-03-03 /pmc/articles/PMC8905718/ /pubmed/35238333 http://dx.doi.org/10.1242/bio.058534 Text en © 2022. Published by The Company of Biologists Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed. |
spellingShingle | Research Article Tao, Chen Liu, Jia Li, Ziqi Lai, Pinglin Zhang, Sheng Qu, Jiankun Tang, Yujin Liu, Anling Zou, Zhipeng Bai, Xiaochun Li, Jianwei DNMT1 is a negative regulator of osteogenesis |
title | DNMT1 is a negative regulator of osteogenesis |
title_full | DNMT1 is a negative regulator of osteogenesis |
title_fullStr | DNMT1 is a negative regulator of osteogenesis |
title_full_unstemmed | DNMT1 is a negative regulator of osteogenesis |
title_short | DNMT1 is a negative regulator of osteogenesis |
title_sort | dnmt1 is a negative regulator of osteogenesis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905718/ https://www.ncbi.nlm.nih.gov/pubmed/35238333 http://dx.doi.org/10.1242/bio.058534 |
work_keys_str_mv | AT taochen dnmt1isanegativeregulatorofosteogenesis AT liujia dnmt1isanegativeregulatorofosteogenesis AT liziqi dnmt1isanegativeregulatorofosteogenesis AT laipinglin dnmt1isanegativeregulatorofosteogenesis AT zhangsheng dnmt1isanegativeregulatorofosteogenesis AT qujiankun dnmt1isanegativeregulatorofosteogenesis AT tangyujin dnmt1isanegativeregulatorofosteogenesis AT liuanling dnmt1isanegativeregulatorofosteogenesis AT zouzhipeng dnmt1isanegativeregulatorofosteogenesis AT baixiaochun dnmt1isanegativeregulatorofosteogenesis AT lijianwei dnmt1isanegativeregulatorofosteogenesis |